Literature DB >> 3918756

Domperidone.

P Critchley, N Langdon, J D Parkes, N P Quinn, J S Shindler, C D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3918756      PMCID： PMC1418525          DOI： 10.1136/bmj.290.6470.788-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Bromocriptine and domperidone in the treatment of Parkinson disease.

Authors:  N Quinn; A Illas; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

2.  The role of D-1 and D-2 receptors.

Authors:  M Schachter; P Bédard; A G Debono; P Jenner; C D Marsden; P Price; J D Parkes; J Keenan; B Smith; J Rosenthaler; R Horowski; R Dorow
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

3.  Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease.

Authors:  G U Corsini; M Del Zompo; G L Gessa; A Mangoni
Journal:  Lancet       Date:  1979-05-05       Impact factor: 79.321

4.  Domperidone and levodopa in Parkinson's disease.

Authors:  J S Shindler; G T Finnerty; K Towlson; A L Dolan; C L Davies; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

5.  Lisuride in the treatment of Parkinsonism.

Authors:  M Schachter; M P Sheehy; J D Parkes; C D Marsden
Journal:  Acta Neurol Scand       Date:  1980-12       Impact factor: 3.209
  5 in total
  3 in total

Review 1.  Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.

Authors:  H D Langtry; S P Clissold
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease.

Authors:  M M Mouradian; I J Heuser; F Baronti; M Giuffra; K Conant; T L Davis; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

3.  Effect of domperidone on the QTc interval in premature infants.

Authors:  A Günlemez; A Babaoğlu; A E Arisoy; G Türker; A S Gökalp
Journal:  J Perinatol       Date:  2009-07-23       Impact factor: 2.521
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.